Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- BAF754 - Provider product page
- Provider
- Novus Biologicals
- Product name
- Goat Polyclonal IL-4 Antibody
- Antibody type
- Polyclonal
Submitted references Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge.
Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.
One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis.
Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Vaccination with irradiated Ancylostoma caninum third stage larvae induces a Th2 protective response in dogs.
Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
Resende LA, Aguiar-Soares RD, Gama-Ker H, Roatt BM, Mendonça LZ, Alves ML, Silveira-Lemos Dd, Corrêa-Oliveira R, Martins-Filho OA, Araújo MS, Fujiwara RT, Gontijo NF, Reis AB, Giunchetti RC
PloS one 2016;11(8):e0161169
PloS one 2016;11(8):e0161169
Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.
Petitdidier E, Pagniez J, Papierok G, Vincendeau P, Lemesre JL, Bras-Gonçalves R
PLoS neglected tropical diseases 2016 May;10(5):e0004614
PLoS neglected tropical diseases 2016 May;10(5):e0004614
One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis.
Costa-Pereira C, Moreira ML, Soares RP, Marteleto BH, Ribeiro VM, França-Dias MH, Cardoso LM, Viana KF, Giunchetti RC, Martins-Filho OA, Araújo MS
BMC veterinary research 2015 Apr 11;11:92
BMC veterinary research 2015 Apr 11;11:92
Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL, Holzmuller P, Gonçalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G
Vaccine 2007 May 22;25(21):4223-34
Vaccine 2007 May 22;25(21):4223-34
Vaccination with irradiated Ancylostoma caninum third stage larvae induces a Th2 protective response in dogs.
Fujiwara RT, Loukas A, Mendez S, Williamson AL, Bueno LL, Wang Y, Samuel A, Zhan B, Bottazzi ME, Hotez PJ, Bethony JM
Vaccine 2006 Jan 23;24(4):501-9
Vaccine 2006 Jan 23;24(4):501-9
Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
Lemesre JL, Holzmuller P, Cavaleyra M, Gonçalves RB, Hottin G, Papierok G
Vaccine 2005 Apr 22;23(22):2825-40
Vaccine 2005 Apr 22;23(22):2825-40
No comments: Submit comment
No validations: Submit validation data